Epithelial ovarian cancer: Definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy

Journal of Radiation Research

Volumn 54, Issue 2, 2013, Pages 322-329

  Yahara, Katsuya ^a   Ohguri, Takayuki ^a   Imada, Hajime ^b   Yamaguchi, Shinsaku ^a   Kawagoe, Toshinori ^a   Matsuura, Yusuke ^a   Hachisuga, Toru ^a   Korogi, Yukunori ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Tobata Kyoritsu Hospital   (Japan)

Author keywords

complete remission; epithelial ovarian cancer; radiotherapy; recurrence

Indexed keywords

CHEMOTHERAPY; DISEASES; TOXICITY; TUMORS;

BRACHYTHERAPY; COMPLETE REMISSION; CONTROL RATES; DEFINITIVE RADIOTHERAPY; EPITHELIAL OVARIAN CANCER; OVARIAN CANCERS; RECURRENCE; RECURRENT TUMORS; TOTAL DOSE; TUMOR SIZE;

RADIOTHERAPY;

EID: 84874844919     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1093/jrr/rrs108     Document Type: Article

References (23)

1. Burke TW, Morris M. Secondary cytoreductive surgery for ovarian cancer. Obstet Gynecol Clin North Am 1994; 21:167-78.
2. Eltabbakh GH, Goodrich S. Update on the treatment of recurrent ovarian cancer. Womens Health (Lond Engl) 2006; 2:127-39.
3. Markman M, Bookman MA. Second-line treatment of ovarian cancer. Oncologist 2000;5:26-35.
4. Homesley HD, Scarantino CW, Muss HB, et al. Concurrent chemotherapy and single high-dose plus whole abdominopelvic radiation for persistent ovarian carcinoma. Gynecol Oncol 1989;34:170-4.
5. Schray MF, Martinez A, Howes AE, et al. Advanced epithelial ovarian cancer: toxicity of whole abdominal irradiation after operation, combination chemotherapy, and reoperation. Gynecol Oncol 1986;24:68-80.
6. Linstadt DE, Stern JL, Quivey JM, et al. Salvage wholeabdominal irradiation following chemotherapy failure in epithelial ovarian carcinoma. Gynecol Oncol 1990;36:327-30.
7. Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000;88:144-53.
8. Milano MT, Katz AW, Muhs AG, et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008;112:650-8.
9. Yeo SG, Kim DY, Kim TH, et al. Curative chemoradiotherapy for isolated retroperitoneal lymph node recurrence of colorectal cancer. Radiother Oncol 2010;97:307-11.
10. Wilkowski R, Thoma M, Bruns C, et al. Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. JOP 2006;7:34-40.
11. Norihisa Y, Nagata Y, Takayama K, et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008;72:398-403.
12. Albuquerque KV, Singla R, Potkul RK, et al. Impact of tumor volume-directed involved field radiation therapy integrated in the management of recurrent ovarian cancer. Gynecol Oncol 2005;96:701-4.
13. Firat S, Erickson B. Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum. Gynecol Oncol 2001;80:213-20.
14. Fujiwara K, Suzuki S, Yoden E, et al. Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy. Int J Gynecol Cancer 2002;12:250-6.
15. Song CW, Rhee JG, Lee CK, et al. Capacitive heating of phantom and human tumors with an 8 MHz radiofrequency applicator (Thermotron RF-8). Int J Radiat Oncol Biol Phys 1986;12:365-72.
16. Abe M, Hiraoka M, Takahashi M, et al. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer 1986;58:1589-95.
17. Imada H. Development of new heating technique. In: Matsuda T, Sugawara T, Abe M, Tanaka Y (eds), Hyperthermia No Rinsho. Tokyo: Iryokagaku, 1999:394-402.
18. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-14.
19. Lanciano R, Reddy S, Corn B, et al. Update on the role of radiotherapy in ovarian cancer. Semin Oncol 1998;25: 361-71.
20. Tinger A, Waldron T, Peluso N, et al. Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma. Int J Radiat Oncol Biol Phys 2001;51:1256-63.
21. Corn BW, Lanciano RM, Boente M, et al. Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure. Cancer 1994;74:2979-83.
22. Gelblum D, Mychalczak B, Almadrones L, et al. Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinoma. Gynecol Oncol 1998;69:36-41.
23. Kim JS, Kim SY, Kim KH, et al. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2003;55:1247-53.